Verano Holdings (VRNO) EBT (QoQ) (2021 - 2026)
Verano Holdings (VRNO) EBT (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Verano Holdings | 433.71 Mn | 348.51 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -69.13% |
| Mar 31, 2026 | 96.41% |
| Dec 31, 2025 | -1,021.92% |
| Sep 30, 2025 | -196.18% |
| Jun 30, 2025 | 174.29% |
| Mar 31, 2025 | 101.83% |
| Dec 31, 2024 | -11,032.57% |
| Sep 30, 2024 | -66.79% |
| Jun 30, 2024 | 31.72% |
| Mar 31, 2024 | 120.21% |
| Dec 31, 2023 | -221.84% |
| Sep 30, 2023 | 84.93% |
| Jun 30, 2023 | -23.40% |
| Mar 31, 2023 | 108.81% |
| Dec 31, 2022 | -920.97% |
| Sep 30, 2022 | 2,000.96% |
| Jun 30, 2022 | -95.09% |
| Mar 31, 2022 | -15.32% |
| Dec 31, 2021 | 99.83% |
| Sep 30, 2021 | 345.84% |